+499.5%
MRNA vs BAH
-28.2%
+527.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BAH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.5% | -0.8% | -1.4% |
| 7D | +5.5% | -3.2% | +8.7% | +7.3% |
| 30D | +158.7% | +2.0% | +156.7% | +168.1% |
| 3M | +182.1% | -7.6% | +189.8% | +192.4% |
| 6M | +151.8% | -5.7% | +157.5% | +159.9% |
| YTD | +393.6% | -11.7% | +405.3% | +407.9% |
| 1Y | +499.5% | -27.4% | +526.8% | +533.6% |
| All | +499.5% | -28.2% | +527.7% | +533.6% |
Cumulative growth
Daily Returns
Daily percentage return beside BAH.
Daily Out/Under-Performance
Portfolio return minus BAH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BAH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BAH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling